Subtopic Deep Dive
Chronic Kidney Disease Classification
Research Guide
What is Chronic Kidney Disease Classification?
Chronic Kidney Disease Classification stratifies CKD stages using K/DOQI and KDIGO guidelines based on estimated glomerular filtration rate (eGFR) and albuminuria levels for risk assessment.
KDIGO guidelines define CKD stages 1-5 by eGFR thresholds below 60 mL/min/1.73m² and albuminuria categories A1-A3 (Levey et al., 2005, 3856 citations). Classification enables prognostic evaluation of progression to end-stage renal disease. Over 100 papers reference these systems for global epidemiology.
Why It Matters
Standardized CKD classification supports consistent diagnosis across clinics, guiding treatment like renin-angiotensin blockade for high-risk stages (Levey et al., 2005). Bikbov et al. (2020, 6137 citations) quantified global CKD burden at 697 million cases, linking stages to cardiovascular mortality. Hill et al. (2016, 3820 citations) meta-analysis showed 9.1% worldwide prevalence, emphasizing classification for epidemiological tracking and resource allocation.
Key Research Challenges
Heterogeneity in Progression Risk
Patients in same CKD stage show variable progression rates due to comorbidities like diabetes (Webster et al., 2016). Coca et al. (2011, 2225 citations) found acute kidney injury doubles chronic CKD risk post-recovery. Refining sub-staging needs dynamic biomarkers beyond static eGFR.
Global Burden Estimation Variability
Prevalence estimates differ by region and assay methods (Hill et al., 2016, 3820 citations). Bikbov et al. (2020) reported 697 million cases but highlighted underdiagnosis in low-income areas. Standardized classification application remains inconsistent.
Integration with Acute Illness
Critically ill CKD patients develop acute-on-chronic injury, complicating staging (De Rosa et al., 2017, 5010 citations). Cheng et al. (2020) linked CKD stages to COVID-19 mortality, underscoring need for real-time risk models.
Essential Papers
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov, Caroline Purcell, Andrew S. Levey et al. · 2020 · The Lancet · 6.1K citations
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
Silvia De Rosa, Sara Samoni, Gianluca Villa et al. · 2017 · Blood Purification · 5.0K citations
Patients with chronic kidney disease (CKD) are at high risk for developing critical illness and for admission to intensive care units (ICU). ‘Critically ill CKD patients' frequently develop an acut...
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto et al. · 2005 · Kidney International · 3.9K citations
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Nathan R. Hill, Samuel Fatoba, Jason Oke et al. · 2016 · PLoS ONE · 3.8K citations
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD). All stages of CKD are associat...
Chronic Kidney Disease
Angela C Webster, Evi Nagler, Rachael L. Morton et al. · 2016 · The Lancet · 3.6K citations
Kidney disease is associated with in-hospital death of patients with COVID-19
Yichun Cheng, Ran Luo, Kun Wang et al. · 2020 · Kidney International · 2.9K citations
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh · 2011 · Kidney International · 2.2K citations
Reading Guide
Foundational Papers
Start with Levey et al. (2005, 3856 citations) for KDIGO definition; then Coca et al. (2011, 2225 citations) on AKI-to-CKD transition; Drüeke et al. (2006, 2081 citations) and Pfeffer et al. (2009, 2045 citations) for stage-specific interventions.
Recent Advances
Bikbov et al. (2020, 6137 citations) for global burden by stage; Cheng et al. (2020, 2889 citations) on acute risks; De Rosa et al. (2017, 5010 citations) for ICU management.
Core Methods
eGFR via MDRD or CKD-EPI equations; albumin-to-creatinine ratio; risk heatmaps plotting categories A1-A3 against GFR stages G1-G5 (Levey et al., 2005).
How PapersFlow Helps You Research Chronic Kidney Disease Classification
Discover & Search
Research Agent uses searchPapers for 'KDIGO CKD staging guidelines' retrieving Levey et al. (2005), then citationGraph maps 3856 citing works on progression risks, and findSimilarPapers uncovers Bikbov et al. (2020) for global burden context.
Analyze & Verify
Analysis Agent applies readPaperContent to extract eGFR formulas from Levey et al. (2005), verifyResponse with CoVe cross-checks claims against Hill et al. (2016), and runPythonAnalysis computes meta-analysis prevalence via pandas on extracted data with GRADE grading for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps like dynamic biomarkers missing in static KDIGO, flags contradictions in anemia trial outcomes (Drüeke et al., 2006 vs. Pfeffer et al., 2009), using latexEditText, latexSyncCitations, and latexCompile for staging diagram reports; exportMermaid visualizes progression heatmaps.
Use Cases
"Meta-analyze CKD prevalence by KDIGO stage from 10 papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation, matplotlib prevalence plots) → outputs CSV of stage-specific rates with GRADE scores.
"Draft review on CKD classification updates post-2020"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro), latexSyncCitations (Levey 2005, Bikbov 2020), latexCompile → outputs PDF manuscript with risk table.
"Find code for eGFR calculator in CKD papers"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets validated Python CKD staging script.
Automated Workflows
Deep Research workflow scans 50+ CKD papers via searchPapers → citationGraph → structured report on KDIGO updates (Levey et al., 2005). DeepScan applies 7-step CoVe to verify progression claims from Coca et al. (2011). Theorizer generates hypotheses on stage-specific interventions from De Rosa et al. (2017).
Frequently Asked Questions
What defines CKD stages per KDIGO?
KDIGO classifies CKD by eGFR <60 mL/min/1.73m² (stages 3-5) or albuminuria >30 mg/g (A2-A3), regardless of cause (Levey et al., 2005).
What methods stratify CKD risk?
Heatmaps combine eGFR and albuminuria categories for progression risk; K/DOQI preceded KDIGO with five stages based solely on GFR (Levey et al., 2005).
What are key papers on CKD classification?
Levey et al. (2005, 3856 citations) established KDIGO; Bikbov et al. (2020, 6137 citations) applied it globally; Hill et al. (2016, 3820 citations) meta-analyzed prevalence.
What open problems exist?
Dynamic reclassification post-AKI (Coca et al., 2011); integrating acute illness (De Rosa et al., 2017); biomarker refinement for stage heterogeneity.
Research Dialysis and Renal Disease Management with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Chronic Kidney Disease Classification with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.